McDermott Will & Schulte, a global law firm

Brad Dennis represents a broad range of healthcare organizations, with a particular focus on complex transactions involving health systems, health plans, innovative joint ventures, and value-based care models. He works with health systems, health plans, investors, and other providers to design and execute deals that advance clinical, financial, and strategic objectives in the evolving healthcare ecosystem.

In the hospital sector, Brad advises nonprofit and for-profit health systems and academic medical centers on acquisitions, divestitures, affiliations, and joint ventures. He is known for balancing governance, regulatory, and business considerations in ways that keep deals moving and create durable partnerships.

Brad centers a significant portion of his practice  on healthcare joint ventures. He has extensive experience structuring and negotiating hospital service line partnerships, joint ventures, and other multiparty collaborations involving health systems, health plans, and for-profit platforms. He is recognized for navigating complex investment, governance, and regulatory issues to align diverse stakeholders and support growth.

In the managed care space, Brad advises on health plan acquisitions; joint ventures; and the development of provider-sponsored health plans, risk-bearing entities, and value-based care “enabler” models. He is at the forefront of transactions that bring providers and payers together, helping organizations evaluate risk, align incentives, and advance sustainable value-based strategies.

Clients rely on Brad for his practical decision-making, deep industry insight, and ability to deliver innovative solutions that bridge business and clinical priorities. He is a trusted advisor in the boardroom and at the deal table, helping organizations make confident decisions in transactions that reshape markets and define the next generation of healthcare models.

Larry C. Guess maintains a general health industry practice, focusing on transactional and regulatory matters. He focuses on representing private equity firms and platform companies, hospitals, health systems and life science companies. Larry has experience with a variety of transactions, including mergers, acquisitions, affiliation and product licensing arrangements. He also provides guidance on regulatory issues such as licensure, corporate practice of medicine, dentistry, physical and speech therapy, and compliance with Stark Law and the Anti-Kickback Statute.

Previously, Larry spent more than a decade in the healthcare industry, marketing pharmaceuticals and medical devices for several Fortune 500 companies. During this time, he brought five multimillion-dollar products to market in major hospital systems across the United States. While in law school, he served as chair of the Accelerated Juris Doctor Board Association. While earning his Master of Business Administration, he served as chair of the Healthcare and Biotech Club, and the Black Management Association.

With a focus on complex transactions and regulatory compliance, Patrick Healy represents a wide range of healthcare industry participants, including non-profit and for-profit health systems, academic medical centers, physician organizations, post-acute providers and health plans. He works alongside his clients to execute their most critical transactions and strategic initiatives, leveraging corporate and healthcare regulatory expertise to drive an efficient and client-oriented approach to achieving his client’s business goals. Patrick has helped his clients navigate and successfully close more than 100 healthcare transactions with a focus on mergers, acquisitions, strategic affiliations, classic and contractual joint ventures and joint operating arrangements.

Patrick also routinely advises clients on a variety of transactional and regulatory matters related to value-based payment programs and delivery systems, leveraging his health economics and healthcare policy backgrounds in doing so. He assists accountable care organizations (Medicare, Medicaid, commercial) and other clinically integrated networks with formation, regulatory compliance, physician and management company joint ventures and participating provider relationships. Patrick advises hospitals and physician groups on their participation in Medicare, Medicaid, commercial bundled-payment and population health payment programs.

Patrick also represents several medication-assisted treatment (MAT) providers and other substance use disorder (SUD) treatment providers with respect to growth strategy and transactions and regulatory compliance, including telehealth providers and portfolio companies operating on a physician practice management platform.

Prior to practicing law, Patrick obtained a Masters in Health Economics from the London School of Economics and was the senior research assistant for health policy in the Economic Studies Program at The Brookings Institution—a Washington, D.C. think tank consistently ranked as the most influential in the world.